News & Events about Axsome Therapeutics Inc.
NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that it will be presenting five abstracts at the upcoming 2023 ...
NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsomes Chief Executive Officer, will ...
Thinking about trading options or stock in Tesla, Coinbase Global, Axsome Therapeutics, Chevron, or Walt Disney? Thinking about trading options or stock in Tesla, Coinbase Global, Axsome Therapeutics, Chevron, or Walt Disney? PR Newswire NEW YORK, Feb. 27, 2023 NEW YORK, Feb. 27, 2023 /PRNewswire...
Globe Newswire
3 months ago
Total fourth quarter net product sales of $24.4 million Auvelity launched October 19th, with fourth quarter net product sales of $5.2 million Sunosi fourth quarter net product sales of $19.2 million Sunosi license agreement for EU announced $66 million upfront, potential milestones up to $101 ...